Sensitivity | Specificity | LR Positive | LR Negative | Positive PV | Negative PV | |||
---|---|---|---|---|---|---|---|---|
N | % (95% CI) | N | % (95% CI) | (95% CI) | (95% CI) | % (95% CI) | % (95% CI) | |
Urine LAM alone | ||||||||
All participants | 17/60 | 28.3 (17.5-41.4) | 254/282 | 90.1 (86.0-93.3) | 2.85 (1.67-4.87) | 0.80 (0.68-0.94) | 37.8 (23.8-53.5) | 85.5 (81.0-89.3) |
CD4 ≥ 100 cells/mm3 | 5/20 | 25.0 (9.0-49.0) | 153/167 | 91.6 (86.3-95.3) | 2.98 (1.20-7.41) | 0.82 (0.63-1.06) | 26.3 (9.0-51.2) | 91.1 (85.7-94.9) |
CD4 < 100 cells/mm3 | 12/32 | 37.5 (21.1-56.3) | 53/61 | 86.9 (75.8-94.2) | 2.86 (1.30-6.27) | 0.72 (0.54-0.96) | 60.0 (36.1-80.9) | 72.6 (60.9-82.4) |
Sputum AFB alone | ||||||||
All participants | 11/60 | 18.3 (9.5-30.4) | 269/282 | 95.4 (92.3-97.5) | 3.98 (1.87-8.44) | 0.86 (0.76-0.97) | 45.8 (25.6-67.2) | 85.6 (80.2-88.4) |
CD4 ≥ 100 cells/mm3 | 4/20 | 20.0 (5.7-43.7) | 158/167 | 94.6 (90.0-97.5) | 3.68 (1.25-10.89) | 0.85 (0.68-1.06) | 30.8 (9.0-61.4) | 90.8 (85.4-94.6) |
CD4 < 100 cells/mm3 | 4/32 | 12.5 (3.5-29.0) | 60/61 | 98.4 (91.2-99.9) | 7.63 (0.89-65.40) | 0.89 (0.78-1.02) | 80.0 (28.4-99.5) | 68.2 (57.4-77.7) |
Urine LAM or sputum AFB* | ||||||||
All participants | 23/60 | 38.3 (26.0-51.8) | 242/282 | 85.8 (81.1-89.7) | 2.70 (1.76-4.16) | 0.72 (0.59-0.88) | 36.5 (24.7-49.6) | 86.7 (82.2-90.5) |
CD4 ≥ 100 cells/mm3 | 7/20 | 35.0 (15.4-59.2) | 145/167 | 86.8 (80.6-91.5) | 2.64 (1.29-5.39) | 0.75 (0.54-1.04) | 24.1 (10.3-43.5) | 91.7 (86.3-95.5) |
CD4 < 100 cells/mm3 | 13/32 | 40.6 (23.7-59.4) | 52/61 | 85.3 (73.8-93.0) | 2.75 (1.32-5.74) | 0.70 (0.51-0.94) | 59.1 (36.4-79.3) | 73.2 (61.4-83.1) |